Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data Transcript
Source: SeekingAlpha
2025-12-02 17:53:25 ET
Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data December 2, 2025 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data Transcript
Jasper Therapeutics Inc. Warrant
NASDAQ: JSPRW
JSPRW Trading
0.0% G/L:
$0.0201 Last:
5,402 Volume:
$0.0201 Open:
JSPRW Latest News
JSPRW Stock Data
$31,744,475
21,939,487
N/A
33
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
